Brief: Syros Pharmaceuticals Regains Compliance With Minimum Bid Requirement
06/10/2022 21:40
Oct 6 (Reuters) - Syros Pharmaceuticals Inc SYRS.O :
* SYROS PHARMACEUTICALS - ON OCT 3, 2022, CO RECEIVED
LETTER FROM
NASDAQ NOTIFYING CO THAT IT HAD REGAINED COMPLIANCE WITH MINIMUM
BID REQUIREMENT
Further company coverage: SYRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Syros Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney
Syros Pharmaceuticals hits record low on QIAGEN deal termination and leadership changes
U.S. STOCKS ON THE MOVE-Charter Communications, BioNTech, Big US banks
U.S. STOCKS ON THE MOVE-BankUnited, Natera, Adaptimmune
Syros falls after blood cancer drug fails in late-stage trial